Viewing Study NCT06826768


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2026-01-31 @ 8:21 AM
Study NCT ID: NCT06826768
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
Sponsor: M.D. Anderson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2024-0326
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View